Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer

The study is a single-center, prospective, non-randomized controlled study. The primary objective is to examine the clinical outcomes of utilizing Deep Inspiration Breath Hold (DIBH) in conjunction with hypo-fractionated radiotherapy for patients diagnosed with left-sided breast cancer with a particular focus on its potential to reduce the incidence of cardiac-related clinical and subclinical events.Participants will revieve large segmentation sadiotherapy ± DIBH for left breast cancer and be followed up to gather their clinical cardiac imformation.

Trial Details

NCT ID
NCT06660628
Phase
NA
Sponsor
Peking Union Medical College Hospital
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Large Segmentation Radiotherapy
  • DIBH
  • Surface guided radiation therapy
  • laser alignment
  • free breathing
Locations (sample)
  • Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

  • 18-70 years old, female, life expectancy \> 5 years
  • ECOG 0, 1, 2 points
  • Pathologically diagnosed with left breast cancer and underwent breast-conserving surgery or modified radical mastectomy
  • The patient will receive radiation therapy to the entire breast or chest wall ± the lymphatic drainage area above and below the clavicle ± the lymp…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →